Positions

Selected Publications

Academic Article

Year Title Altmetric
2021 Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma.  Human Pathology.  108:42-50. 2021
2019 Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi‐institutional study.  Cancer Cytopathology.  127:377-389. 2019
2019 Management of patients with renal mass lesions based on renal biopsy cytology results.  Human Pathology.  85:270-278. 2019
2016 Primary pancreatic leiomyosarcoma with metastasis to the liver diagnosed by endoscopic ultrasound-guided fine needle aspiration and fine needle biopsy.  Diagnostic Cytopathology.  44:1070-1073. 2016
2016 Comprehensive Histologic Scoring to Maximize the Predictability of Pathology-generated Equation of Breast Cancer Oncotype DX Recurrence Score.  Applied Immunohistochemistry and Molecular Morphology.  24:703-711. 2016
2012 Complex of myoglobin with phenol bound in a proximal cavity 2012
2011 Amphitrite ornataDehaloperoxidase (DHP): Investigations of Structural Factors That Influence the Mechanism of Halophenol Dehalogenation Using “Peroxidase-like” Myoglobin Mutants and “Myoglobin-like” DHP Mutants.  Biochemistry.  50:8172-8180. 2011
2010 Replacement of Val3 in Human Thymidylate Synthase Affects Its Kinetic Properties and Intracellular Stability,.  Biochemistry.  49:2475-2482. 2010
Metastatic Pancreatic Adenocarcinoma to a Lymph Node with Diffuse Large B Cell Lymphoma: A Case Report and Review of the Literature.  International Journal of Cancer and Clinical Research.  3.
Primary adrenal gland epithelioid sarcoma: A case report and literature review.  Diagnostic Cytopathology. 

Education And Training

  • Doctor of Philosophy in Medical Biochemistry, Medical University of South Carolina 2010
  • Doctor of Medicine, Xinxiang Medical University 2003

    • Awards And Honors

    Full Name

  • Xiao Huang